Management of COPD: Early identification and active intervention are crucial

Postgraduate Medicine

Volumn 103, Issue 4, 1998, Pages 129-141

  Ferguson, Gary T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIOXIDANT; BITOLTEROL MESILATE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; ISOETARINE; ISOPRENALINE; MUCOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORCIPRENALINE; PIRBUTEROL ACETATE; PROTEINASE INHIBITOR; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE SULFATE; THEOPHYLLINE; UNCLASSIFIED DRUG;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; COR PULMONALE; DYSPNEA; EARLY DIAGNOSIS; HUMAN; HYPERCAPNIA; HYPOXEMIA; SMOKING CESSATION;

EID: 0031959761     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.04.439     Document Type: Conference Paper

References (34)

1. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993;328(14):1017-22
2. Celli BR, Snider GL, Heffner J, et al for the American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(5 Pt 2):S77-121
3. Siafakas NM, Vermeire P, Pride NB, et al for the European Respiratory Society Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8(8):1398-420
4. Higgins MW. Epidemiology of obstructive pulmonary disease. In: Casaburi R, Petty TL, eds. Principles and practice of pulmonary rehabilitation. Philadelphia: Saunders, 1993:10-17
5. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317(21):1309-14
6. Campbell AH, Barter CE, O'Connell JM, et al. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985;40(10):741-8
7. Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997;10(6): 1380-91
8. 1: the Lung Health Study. JAMA 1994;272(19):1497-505
9. Smoking Cessation Clinical Practice Guideline Panel and Staff. The Agency for Health Care Policy and Research smoking cessation clinical practice guideline. JAMA 1996;275(16):1270-80
10. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337(17):1195-202
11. Pauwels RA, Lofdahl CG, Pride NB, et al. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP): hypothesis and design. Eur Respir J 1992;5(10):1254-61
12. 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316(17):1055-62
13. 1-antitrypsin: a world view. Chest 1996;110(Suppl):237-94S
14. Britton JR, Pavord ID, Richards KA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995;151(5):1383-7
15. Skorodin MS. Pharmacotherapy for asthma and chronic obstructive pulmonary disease: current thinking, practices, and controversies. Arch Intern Med 1993;153(7):814-28
16. Ziment I. Pharmacologic therapy of obstructive airway disease. Clin Chest Med 1990;11(3):461-86
17. Gross NJ, Petty TL, Friedman M, et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease: a three-center study. Am Rev Respir Dis 1989;139(5):1188-91
18. Coughlin SS, Metayer C, McCarthy EP, et al. Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol 1995;142(4):395-403
19. Murciano D, Auclair MH, Pariente R, et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 1989;320(23):1521-5
20. Martin RJ, Pak J. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145(3):540-4
21. COMBIVENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: an 85-day multicenter trial. Chest 1994;105(5):1411-9
22. Thomas P, Pugsley JA, Stewart JH. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Chest 1992;101(1):160-5
23. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991;114(3):216-23
24. Weir DC, Gove RI, Robertson AS, et al. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990;45(2):112-7
25. Boman G, Bäcker U, Larsson S, et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983;64(6):405-15
26. Anthonisen NR, Manfreda J, Warren CW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204
27. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146(4):1067-83
28. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325(21):1453-60
29. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-8): 1-24
30. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995;333(11):710-4
31. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333(13):817-22
32. Light RW, Muro JR, Sato RI, et al. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;139(1):126-33
33. Celli BR. Pulmonary rehabilitation in patients with COPD. Am J Respir Crit Care Med 1995;152(3):861-4
34. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122(11):823-32